Your Pocket Size Dental Drug Reference

Your Pocket-Size Dental Drug Reference 2012 Edition A Handbook of Commonly Used Dental Medications Useful in the Management of Oral Diseases and Conditions by Michael A Kahn, D.D.S © 2012 www.ajlobby.com People’s Medical Publishing House-USA Enterprise Drive, Suite 509 Shelton, CT 06484 Tel: 203-402-0646 Fax: 203-402-0854 E-mail: info@pmph-usa.com © 2012 PMPH-USA, Ltd All rights reserved Without limiting the rights under copyright reserved above, no part of this publication may be reproduced, stored in or introduced into a retrieval system, or transmitted, in any form or by any means (electronic, mechanical, photocopying, recording, or otherwise), without the prior written permission of the publisher 11 12 13 14/PMPH/9 ISBN-13: 978-1-60795-161-2 ISBN-10: 1-60795-161-4 Printed in China by People’s Medical Publishing House Copyeditor/Typesetter: Spearhead Global, Inc Cover Designer: Mary McKeon Library of Congress Cataloging-in-Publication Data Kahn, Michael A Your pocket-size dental drug reference : a handbook of commonly used dental medications useful in the management of oral diseases and conditions / by Michael A Kahn — 2012 ed p ; cm Includes bibliographical references and index ISBN-13: 978-1-60795-161-2 ISBN-10: 1-60795-161-4 I Title [DNLM: Pharmaceutical Preparations—Handbooks Dentistry— Handbooks QV 39] 617.6Ј061—dc23 2012005636 Notice: The authors and publisher have made every effort to ensure that the patient care recommended herein, including choice of drugs and drug dosages, is in accord with the accepted standard and practice at the time of publication However, since research and regulation constantly change clinical standards, the reader is urged to check the product information sheet included in the package of each drug, which includes recommended doses, warnings, and contraindications This is particularly important with new or infrequently used drugs Any treatment regimen, particularly one involving medication, involves inherent risk that must be weighed on a case-by-case basis against the benefits anticipated The reader is cautioned that the purpose of this book is to inform and enlighten; the information contained herein is not intended as, and should not be employed as, a substitute for individual diagnosis and treatment www.ajlobby.com Sales and Distribution Canada McGraw-Hill Ryerson Education Customer Care 300 Water St Whitby, Ontario L1N 9B6 Canada Tel: 1-800-565-5758 Fax: 1-800-463-5885 www.mcgrawhill.ca Foreign Rights John Scott & Company International Publisher’s Agency P.O Box 878 Kimberton, PA 19442 USA Tel: 610-827-1640 Fax: 610-827-1671 Japan United Publishers Services Limited 1-32-5 Higashi-Shinagawa Shinagawa-ku, Tokyo 140-0002 Japan Tel: 03-5479-7251 Fax: 03-5479-7307 Email: hayashi@ups.co.jp United Kingdom, Europe, Middle East, Africa McGraw Hill Education Shoppenhangers Road Maidenhead Berkshire, SL6 2QL England Tel: 44-0-1628-502500 Fax: 44-0-1628-635895 www.mcgraw-hill.co.uk Singapore, Thailand, Philippines, Indonesia Vietnam, Pacific Rim, Korea McGraw-Hill Education 60 Tuas Basin Link Singapore 638775 Tel: 65-6863-1580 Fax: 65-6862-3354 www.mcgraw-hill.com.sg Australia, New Zealand, Papua New Guinea, Fiji, Tonga, Solomon Islands, Cook Islands Woodslane Pty Limited Unit 7/5 Vuko Place Warriewood NSW 2102 Australia Tel: 61-2-9970-5111 Fax: 61-2-9970-5002 www.woodslane.com.au Brazil SuperPedido Tecmedd Beatriz Alves, Foreign Trade Department R Sansao Alves dos Santos, 102 | 7th floor Brooklin Novo Sao Paolo 04571-090 Brazil Tel: 55-16-3512-5539 www.superpedidotecmedd com.br India, Bangladesh, Pakistan, Sri Lanka, Malaysia CBS Publishers 4819/X1 Prahlad Street 24 Ansari Road, Darya Ganj, New Delhi-110002 India Tel: 91-11-23266861/67 Fax: 91-11-23266818 Email:cbspubs@vsnl.com People’s Republic of China People’s Medical Publishing House International Trade Department No 19, Pan Jia Yuan Nan Li Chaoyang District Beijing 100021 P.R China Tel: 8610-67653342 Fax: 8610-67691034 www.pmph.com/en/ www.ajlobby.com www.ajlobby.com Metric System Weight kilogram = kg = 1000 gram gram = g = gram milligram = mg = 0.001 gram microgram = μg = 0.001 milligram Volume liter = L = 1000 milliliters milliliter = ml = 0.001 liter Metric and Apothecary Equivalents Weight Equivalents—Approximate Metric Apothecary mg 1/65 grain 65 mg grain 32 mg /2 grain 324 mg grains 1g 15.432 grains 31.103 g ounce (oz) Volume Equivalents—Approximate Metric Apothecary >1.0 ml 16.23 minims 4.0 ml fluid dram 30 ml fluid ounce (oz) 480 ml pint 960 ml quart Household Equivalents—Approximate Utensil Volume teaspoonful (tsp) ml tablespoonful (tbsp) 15 ml teacupful 120 ml tumbler glassful 240 ml Clark’s Rule child’s weight (lb) × adult dose = child’s dose 150 v www.ajlobby.com Weight lb/kg Chart kg = 2.2 lb Kilograms (kg) >10 20 25 30 35 40 45 50 55 60 Pounds (lb) 22 44 55 66 77 88 99 110 121 132 vi www.ajlobby.com FOREWORD This pocket-size booklet is a compilation of prescribed drugs and therapeutic regimens useful in the treatment of common oral diseases and conditions Its content is not intended to be all-inclusive but is provided to give an overview of the pharmaceuticals available and the protocols that have been developed The number of medications within each category has intentionally been limited so that the booklet may be conveniently placed in a clothing apparel pocket Oral pathologists and other clinicians who have an interest in oral medicine have successfully used the specialized protocols listed; some regimens are off-label use The author acknowledges that the same treatment objectives may be accomplished by many pharmacological and therapeutic approaches Brand names are included for the convenience of identification No advertisement or promotional support is accepted from any company or interest The drugs are grouped according to their class of action or use for a specific condition Every effort has been made to ensure that drug selection and dosage are in accordance with current recommendations and practice; however, in view of ongoing research, changes in governmental regulations, and new drug reactions, the clinician is urged to check the package insert or back label of each drug for any change in indication or dosage and for warnings and precautions For any given patient, the drug, dosage, and administration may vary from the accepted norm, depending on the clinical situation As with any therapeutic procedure, the clinician has the responsibility to determine whether there are any contraindications to the proposed therapy, be aware of the potential complications and side effects, and inform the patient of such possibilities The following must always be considered for possible contraindications: medical history, pregnancy, nursing mothers, children, known hypersensitivities, the elderly or medically compromised, patients with impaired renal or hepatic function, concurrent medications, and full-disclosure labeling vii www.ajlobby.com PREFACE TO THE FIFTEENTH EDITION As in past editions, there is a limited increase in the number of medications listed within certain categories and several medications’ regimens have been updated, revised, or deleted from the previous edition Unless specifically noted, the medication regimens included in this booklet are intended for the adult population A list of prescription requirements and safe writing practices is included A chart of weight and equivalents is on the inside front cover; the newly revised indications for American Heart Association’s guidelines of antibiotic prophylaxis for bacterial endocarditis prevention during dental procedures is located on the inside back cover Every effort has been made to ensure the accuracy of the contents of this booklet; however, the author is not responsible for any typographical errors and the clinician should always verify the accuracy of the information provided A special thanks to my colleagues Drs J Michael Hall and Lynn Solomon for their helpful manuscript suggestions Michael A Kahn, D.D.S Professor and Chairman Department of Oral and Maxillofacial Pathology—Suite DHS-646 Tufts University School of Dental Medicine Kneeland Street Boston, MA 02111 December, 2011 viii www.ajlobby.com TABLE OF CONTENTS I Antibiotics and Antimicrobials II Antihistamines and Palliative Coating Agents (Magic Mouthwashes) 12 III Topical Anesthetics, Chemical Cauterizers, and Keratolytic Agents .14 IV Antifungals 17 V Immunosuppressives, Occlusive Dressings, and Compounds 24 VI Antiviral Agents/Viral-Blocking Agents/ Germicidals .46 VII Muscle Relaxants .51 VIII Antianxiety Agents (Anxiolytics) for Stress Management 53 IX Antidepressants 55 X Analgesics 55 XI Local Anesthetics .64 XII Vasoactive Drugs .66 XIII Antixerostomics and Fluoride Gels/Rinses 67 XIV Tooth Desensitizers 75 XV Hemostatic Agents (Topical and IV) 76 XVI Burning Mouth Syndrome, Neuralgia, and Myofascial Pain 78 XVII Nutrient Deficient and Supplement Therapy .84 XVIII Taste and Smell Disorder Therapies 85 XIX Miscellaneous Over-the-Counter Oral Rinses and Products to Relieve Mouth Pain 86 XX Herbal and Nonherbal Remedies 90 XXI Management of Patients Receiving Radiation or Chemotherapy 93 XXII HIV Infection and AIDS .97 XXIII Halitosis 99 XXIV Prescription Requirements and Safe Writing Practices 100 Compounding Centers of America Phone Contact 101 Dangerous Prescription Abbreviations 101 Relative Potencies of Selected Topical Corticosteroids 102 References 103 Index 109 ix www.ajlobby.com Clostridium, 1, Clotrimazole 1% and betamethasone cream, 18 1% cream, 18 10 mg/ml suspension, 19 troches 10 mg, 18 200 mg, 24 vaginal cream, 1%, 24 Clozapine, 72 CNS stimulants, 4, 67 Coagulation disorders, 77 Coating agents, palliative, 12 Coccdioides, 20 Codeine allergy to, 63 contraindications for, 54, 56 overview of, 59 sensitivity to, 62 Colchicine 0.6 mg, 39 Colgate Sensitive Pro-Relief Desensitizing paste, 75 Total® toothpaste, 10 Colitis pseudomembranous, 10 as side effect, Combivir, 97 Combunox, 61 Compazine, 55 Condyloma acuminatum, 17 Constipation, as side effect, 13 Corticosteroids, topical, relative potencies of, 102–103 Coumadin, 6, 58 Crixivan, 98 Cryptococcus, 20 Cut-Trol, 78 Cyclobenzaprine HCl extended release 15 mg capsules, 52 10 mg, 52 Cyclosporine concurrent use of, 18 influential factors, toxicity, Cycoflex, 52 Cyklokapron, 77–78 Chlorthalidone, 67 Chlorzoxazone 250 mg, 52 with acetaminophen 500 mg tablet, 52 Chondroitin sulfate, 91 Chromomycosis, 20 Chronic vestibular/bulla diseases, 24–28 CHX, Cimetidine drug interactions, 49 200 mg, 45 Cipro, Ciprofloxacin 250–750 mg, Circulatory depression, 63 Cisapride, contraindications, Citanest Forte/Citanest Plain, 65 Clarithromycin 250 mg, 4–5 500 mg, 4–5, 107 Cleosin HCl, Pediatric, Clindamycin influential medications, 150 mg or 300 mg, 600 mg, 107 75 mg/5 ml, Clinitest, influential factors, Clinpro 5000, 74 Clobetasol, 41 Clobetasol, 0.05%, propionate cream or ointment, 102 gel or ointment, 30–31 and nystatin 100,000 IU/ml aqueous solution, 31 ointment with Orabase or Orabase with benzocaine, 31 Clofazimine soft gelatin 50 mg capsules, 39 Clonazepam 0.25 mg, 80 0.5 mg, 80–81 Clonidine characterized, 67, 72 dipotassium 7.5 mg, 53 114 www.ajlobby.com Diflunisal 250 or 500 mg, 56 Digoxin contraindications for, 66 drug interactions, 49 toxicity, 6–7, 56 Dihydrocodeine bitartrate 16 mg, aspirin 356.4 mg, caffeine 30 mg, 60 Dilantin characterized, 82–83 toxicity, 56 Dilaudid, 63 Diltiazem 60 mg, 66 Diphenhydramine elixir 12.5 mg/5 ml, 12 elixir 12.5 mg/tsp, 81 (12.5 mg/5 ml) 173 ml, with tetracycline, 44 HCl 50 mg, 12 Diprolene, 30 Diuretics, 67 Docosanol, 10%, cream, 50 Dolobid, 56 Domeboro astringent, 50 Doxepin HCl 25 mg, 55, 81–82 Doxycycline hyclate 10.0%, 100 mg, 40 20 mg, 200 mg, 5–6 Dressings burn, 45 occlusive, 24–28 wound, 45 Droxia, 98 Dry mouth, symptom relief, 67–71 Duraphat, 76 Dycill, Dyclone®, 14 Dyclonine HCl with acyclovir ointment, 46 0.5% or 1%, 14 Dynapen, Dysphonia, 29 Cytochrome P450 inhibition, Cytotec, 41 Dapsone 25 mg, 39–40 Darunavir, 97 Deafferentation pain, 79, 83 Debacterol®, 15–16 Decadron, 31 Decapinol, 25 Delaviridine, 98 Delmopinol HCl mouth rinse, mg/ml, 25 Deltasone, 35, 64 Demerol, 63 Denavir, 49 Dental chewing gums, over-thecounter, 68–69 Dentures See Removable prostheses disinfectants/ cleaners Depression, 55, 83, 93 Dermatoid arthritis, 92 Desipramine, 67 Desyrel, 55, 83 Dethylproprion, 67 Dexamethasone elixir 0.5 mg/5 ml, 31–32 (0.5 mg/5 ml) ml, with lidocaine, 40 (0.5 mg/5 ml) ml, with tetracycline, 44 0.75 mg, 34 sodium phosphate injectable mg/ml with lidocaine HCl, 32 suppression test, 83 Diabetic patients, medication guidelines for, 18, 28, 35, 40, 45 Diazepam characterized, 44, 66 mg, 54 mg, 81 Dicloxacillin 250 mg and 500 mg, Dicyclomine, 67 Didanosine, 97 Diflucan, 19 Easy Gel, 73 Echinacea, 91–92 Ecotrin, 57 115 www.ajlobby.com myogenic, 51–54 psychogenic, 55, 82–83 Famciclovir, 500 mg, 48–49 Famvir, 48–49 Fentanyl buccal effervescent lozenge 100, 200, 400, 600, 800 :g, 62–63 Fentora, 62–63 Ferrous sulfate 250 mg, 84 Fioricet, 58–59 Fiorinal, 56, 58–59 Flagyl, Flavoxate, 67 Flexeril, 52 Flo Gel, 72–73 Fluconazole characterized, 19 contraindications for, 45 100 mg tablets, 19 100 mg tablets/hydrocortisone 10 mg and iodoquinol 10 mg, 19 Flucytosine 250 mg or 500 mg, 19–20 Fluocinolone, 0.05% gel, 32 gel or ointment, 32–33 ointment compounded with 1:1 with Orabase with benzocaine, 33 Fluocinonide acetonide 0.25% ointment or cream, 103 contraindications for, 41 0.05% cream, gel, ointment, or solution, 102 Fluoride gels/rinse, 67–75 Fluoridex, 74 Fluoridex Maximum Uptake, 75 Fluorigard, 75 Fluorocare Neutral, 74 Time Saver, 74–75 Fluoxetine HCl 20 mg, 55, 82 Folic acid deficiency, 84 0.4 mg, 84 EES, 6–7 Efavirenz, 98–99 Elavil, 79 Elderly patients, cautionary notes for, 40, 52, 57, 59, 63 Elidel, 34 E-mycin 250 mg, Empirin, 57 Emtricitabine, 97, 99 Emtriva, 97 Enfuvirtide, 98 Enisyl, 51 Ensure-Plus, 85 Enterobacter spp., 10 Enterococci, effective medications against, Epinephrine, 64–65, 78 Epivir, 97 Epzicom, 97 Eraxis, 17–18 Ergot, 66 Ergotamine tartrate with caffeine suppositories, 66 Erosive/ulcerative diseases, 24–28 Ery-Tab, 6–7 ERYC, 6–7 EryPed, Erythema influential factors, 10 multiforme, 13, 32, 34–36, 38, 44, 47 Erythromycin, characterized, 4, Erythromycin ethylsuccinate 400 mg, 6–7 oral suspension 200 mg/5 ml, Erythromycin stearate 500 mg, Escherichia coli, 10 Esophagitis, 57 Etodolac 200 mg, 56 Eugenol, 25 Evoxac, 70 Facial arteries, 64 Facial pain midface vascular, 66 myofascial, see Myofascial pain 116 www.ajlobby.com over-the-counter regimens, 99 tongue cleaners, 99 Halobetasol 0.05%, propionate gel, 33 propionate 0.05% cream or ointment, 102 Haloperidol, 67 Headache characterized, 79 cluster, 66 medication guidelines for, 51–52 midface cluster, 66 migraine, 66, 93 Head and neck pain, nonanalgesics for, 64 Health-Dent desensitizer with fluoride, 75 Hematology hematological disorders, 39 hemodynamics, influential factors, 70 platelet aggregation, influential factors, 61 platelet dysfunction, 57 steroid therapy and 28–29 see also Anemia Hematopoietic stem cell transplant patients, 22 HemCon dental dressing, 76–77 Hemolysis, 40–41 Hemostatic agents intravenous, 77–78 topical, 76–77 Hemostatsyl hemostatic agent, 77 Hepatoxicity, 28, 44 Herbal remedies, 90–93 Herpes gingivostomatitis, primary, 46 labialis, primary and recurrent, 46–50 oral, 47 simplex, orofacial, 50 simplex virus (HSV), 47 zoster, 46 Herpetic gingivostomatitis, 13 Histoplasmosis, 20 HIV immunogen, 98 Food and Drug Administration (FDA) guidelines, 14, 25, 27, 30, 32, 34, 43, 56, 58, 62, 88 Food supplements, 85 Fosamprinavir, 98 Fungizone®, 17 Fuzeon, 98 Gabapentin 100 mg (300 mg, 400 mg), 82 Gammagard liquid, 40 Gammar P-IV, 40 Gamunex, 40 Gastritis, 57 Gastrointestinal bleeding, risk for, 57–58, 62 Gastrointestinal diseases and disorders, 2, 39 Gelclair bioadherent gel, 26, 94 Gel-Kam, 72–73 Gel-Pro Control, 72–73 Gel-Tin, 73 Germicidals, 46–517 Gingivitis control, 95–96 necrotized ulcerative, 11 ulcerative, 7, 76 Ginkgo, 92 Ginseng, 92–93 Glaucoma, 12, 70 Gluma, 76 Glutaraldehyde/hydroxyethyl methacrylate (HEMA), 76 Gonorrhea, oral, Gram-negative anaerobes, Griseofulvin, 86 Guanethidine, 67 Guanifenesin 10% in speed gel, 52–53 Gyne-Lotrimin, 24 Haemophilus spp., characterized, influenzae, 1, 10 Hairy tongue, 17 Halitosis chemical products, 99 117 www.ajlobby.com valerate 0.2% cream or ointment, 102 Hydromorphone HCl mg, 63 Hydroxyurea, 98 Hydroxyzine pamoate 25 mg, 54 25 mg, 54 Hypertension, 60–61, 66, 71 Hypertensive agents, 67 Hypoglycemia, 83 Hypotension, 63 HIVID, 97 HIV infection cellular inhibitor, 98 entry inhibitor, 98 fusion inhibitor, 98 HIV integrase strand transfer inhibitor, 98 immune-based therapy, 98 mononucleoside/nucleotide reverse transcriptase inhibitors, 98 multiclass combination product, 99 nucleoside reverse transcriptase inhibitors, 97 protease inhibitors, 97–98 Hormone suppression, 90 H2-blockers, 54 Human immunodeficiency virus See HIV immunogen; HIV infection Hurricaine, 14 Hydra, 98 Hydrochlorothiazide toxicity, 56 Hydrocodone bitartrate 7.5 mg and acetaminophen 750 mg, 60 7.5 mg and ibuprofen 200 mg, 60–61 10 mg and acetaminophen 650 mg, 60 Hydrocodone mg and acetaminophen 500 mg, 59 Hydrocortisone actetate ointment, 0.5%, 24 1%, with polymyxin B, bacitracin, neomycin cream compounded 1:1 with 5% lidocaine ointment, 33 1% cream or 2.5% ointment, 103 10 mg, with fluconazole and iodoquinol 10 mg, 19 10 mg and iodoquinol 10 mg, 20 2% and iodoquinol 1%, 20 Ibuprofen characterized, 61 400 mg, with acetaminophen 1000 mg, 62 400 mg, with oxycodone HCl mg, 61 200 mg, 58 200 mg, with hydrocodone bitartrate, 60 800 mg, 57 Idoxyuridine, 86 IDP Gel-oh, 72–73 Ileus, paralytic, 61 Imipramine, 67 Immune-depressed patients, 22 Immune globulin, intravenous, 40 Immunocompromised patients, 42, 49 Immunomodulators, topical, 43 Immunosuppresant therapy, 41, 43 Immunosuppressed patients, 29, 46–47 Immunosuppressives, 24–28 Imuran, 38 Indinavir, 98 Indocin toxicity, 56 Infants clotrimazole 10 mg/ml suspension, 19 congenital malformations, 42 lidocaine HCl viscous, 2%, 15 Infection, medication guidelines for 118 www.ajlobby.com Ketoconazole cream 2% or mixed with equal parts of triamcinolone acetonide 0.1% or 0.5% ointment, or fluocinonide 0.05% ointment, or clobetasol 0.05% ointment, 21 200 mg, 21 Ketorolac nasal spray, 61 tromethamine 10 mg, 59 Kidney diseases and disorders compromised renal status, 57 contraindicated medications, 6–7, 10 end-stage renal disease, renal-compromised patients, medication cautions for, 1, 3, 5, 8–9 renal dysfunction, as side effect, renal impairment, 47, 78 medications to avoid, 5, 39–40, 63, 78 nephrotoxic medications, 40 Klebsiella spp., 10 Klonopin, 80–81 acute, 6–7 aspergillus, 18, 20, 22 bacterial, oral, Bacteroides, C difficile, 10 Candida, 17, 21 fungal, 19 herpes simplex, 47, 51 HIV management, 97–99 lower respiratory, 1, 6–7 ontogenic, penicillin-resistant, penicillinase-resistant, periodontal, skin, soft tissue, 2, 6–7 staph, steroid treatment, 28 upper respiratory, 1, 4, 6–7, 92 urinary tract, 92 Infectious disease, medication guidelines for, 35, 92 Interleukin-2, 98 Invirase, 98 Iodine, allergies to, 11 Iodoform, 25 Iodoquinol with hydrocortisone 10 mg, 20 10 mg, with fluconazole and hydrocortisone 10 mg, 19 with 2% hydrocortisone, 20 Iritis, acute, 70 Isentress, 98 Isocaine 3%, 65 Itraconazole characterized, 20 100 mg, 20 10 mg/ml oral solution, 20–21 Iveegam EN, 40 Laclede ORALBalance®, 69 Lactinex tablets, 45 Lamivudine (3TC), with abacavir or zidovudine, 97 Lamprene, 39 L pneumophila, Legionnaire’s disease, Lesions herpes simplex, 28, 49 genital, 46 gingival, 29 vesiculoulcerative, 13–16 Leukoencephalopathy, 42 Leukoplakia, 96 Levodopa, 72, 86 Levornordefrin, 65 Lexiva, 98 Librium, 53, 80 Lidex, 21, 32–33 Kaletra, 98 Kamillosan, 84 Kaopectate, 12Keflex, 2–3 Kenalog, 21, 36, 38 Kepivance, 95 Keratolytic agents, 16–17 Ketaconazole, 45 Ketaprofen 12.5 mg, 57–58 119 www.ajlobby.com overdose management, 66 reversal agent, 66 Lodine, 56 Loop diuretics, 67 Lopinavir, 98 Lorazepam characterized, 72 0.5 mg, 82 mg, 54 Lorcet, 60 Lortab mg, 59 Lotrimin AF/Lotrimin-Rx, 18 Lymphoma, 43 Lymphoproliferative disorders, 41 Lyphocin, 10 Lidocaine characterized, 45 mixed with capsaicin cream, 79 ointment, 5%, 15 1%, with acyclovir ointment, 46 with triamcinolone acetonide suspension, 37 2%, with 1:100,000 epinephrine, 64 2.5%, with 2.5% prilocaine periodontal gel, 64–65 viscous, 2%, 100 ml, tetracycline oral suspension (125 mg/5 ml) 18 ml, dexamethasone (0.5 mg/5 ml) ml, nystatin oral suspension (100,000 IU) 73 ml, 40 Lidocaine HCl liquid, 5%, 15 viscous, 2%, 14–15 Lincomycin, Lioresal, 51 Listerine®, 10 Listermint with fluoride, 75 Lithium characterized, 72 salts, 86 toxicity, 56 Liver diseases and disorders cirrhosis, compromised hepatic status, 57 hepatic dysfunction, as side effect, hepatic impairment, hepatic toxicity, 92 liver damage, as side effect, 20–21 medications to avoid, 1, 5–7, 59, 63 L-Lysine 500 mg, 51 Local anesthetics amides, 64–65 characterized, 38 esters, 65–66 Manapol patch, 27 MAO-Is, 12, 59–60, 62, 65, 67, 92–93 Maraviroc, 98 Marcaine, 64 Mary’s magic potion, 13 Maxisal liquid, 67 Medically compromised patients, 65 Medihoney, 45 Men’s health guidelines benign prostatic hypertrophy, 93 male fertility, 39 Mepergan fortis, 63 Meperidine HCl 50 mg characteristics of, 63 promethazine HCl 25 mg, 63 Mepivicaine 3%, 65 Mepivicaine HCl 2%, with Levonordefrin 1:20,000, 65 3%, plain, 65 Meritene, 85 Metformin, 86 Methantheline bromide, 67 Methemoglobinemia, sources of, 14–15, 31, 88 Methicillin, Methotrexate toxicity, 56 2.5 mg, 40–41 Methyldopa, 67 120 www.ajlobby.com Methylprednisone mg, 34 Metronidazole characterized, 45, 86 500 mg, Micafungin sodium 50 mg, 21–22 Miconazole buccal 50 mg tablets, 22 nitrate vaginal cream, 2%, 24 Miles’ Mixture, 29 Milk of Magnesia, 12 Minocycline mg bioresorbable powder in a disposable cartridge, 7–8 Minute-Gel, 74–75 Misoprostol, 41 Monistat 7, 24 Monoamine oxidase-inhibitors See MAO-Is M catarrhalis, Motrin, 57–58 Mouth pain relief, over-thecounter oral rinses, 86–90 Mouth rinses, see Oral rinses; Mouthwash alkaline saline, 93 Biotene®, 94 chlorhexadine, 42, 44 neutral calcium2+/PO, 94 radiation or chemotherapy patient management, 93–97 sucralfate suspension g/10 ml, 95 Mouthwash chlorhexidine, 40 chlorhexadine gluconate, 0.12%, 95 chlorhexadine gluconate, 0.12%, without alcohol, 95–96 magic, 12 Oasis®, 68 prednisone, 20 mg tablets and 0.12% chlorhexidine gluconate, 35 Weisman’s Philadelphia mouthwash, 13 Mucoadhesive biodegradable discs, over-the-counter, 69–70 Mucositis, 13 Mucotrol 2.2 g wafer, 95 MuGard mucoadhesive oral wound rinse, 94 Muscle relaxants, 51–53, 67 Mycamine, 21–22 Mycelex, 18 Myclog II, 23 Mycophenolate mofetil 250 mg and injection, 41–42 Mycoplasma spp., Mycostatin, 22–23 Myfortic, 41–42 Myofascial pain characterized, 79 over-the-counter medications, 83–84 overview of medications, 78–83 Mytrex, 23 Naproxen sodium 275 mg, 57–58 Narcotics, 67 Negatan®, 16 Nelfinavir, 98 Neo-Cobefrin, 65 Nephrolithiasis, 70 Neuralgia glossopharyngeal, 64 over-the-counter medications, 83–84 overview of medications, 78–83 postherpetic, 47–49 sphenopalatine, 66 trigeminal, 64 Neurontin, 82 Neutral sodium fluoride 0.2%, 73 1.1% dental cream, 73–74 1.1% dental paste with tricalcium phosphate, 74 1.1% 5000 ppm with potassium nitrate toothpaste with sensitivity relief, 74 1.1% or 1.0%, gel, 73 2.0%, 74 121 www.ajlobby.com Octocaine, 64 Omni-Gel, 72–73 Onsolis, 63 Opana/Opana ER, 61–62 Opiates, 86 Opioids, 12, 56, 62–63 Orabase with benzocaine, 15, 33, 36 characterized, 31, 36 HCA, 24 Sooth-N-Seal, 27 Orajel Protective MouthSore Discs, 27 Oral canker sore patch, 26 Oral contraceptives, influential medications, 4, 10 Oral erosive lichen planus, 24, 30–38, 40–44 Oral Health’s XyliMelts®, 69 Oral leukoplakia, 25 Oral moisturizing gels, over-thecounter, 69 Oral rinses BetaCell, 25, 96 delmopinol HCl mouth rinse, mg/ml, 25 Listerine®, 11 for mouth pain relief, 86–88 1-2-3 mouth rinse, 13 PerioShield, 10 10% povidone-iodine solution, 10 0.12% chlorhexidine gluconate without alcohol, Oral wound rinse, MuGard mucoadhesive, 94 OraMoist® mucoadhesive patch, 27, 70 OraPatch, 27–28 Oraqix, 64–65 OraVerse, 66 Oravig, 22 Orazinc 220 mg, 85 Orthodontic appliance sores, 25 Orudis, 57 Orudis KT, 58 Otitis media, Oxybutynin, 67 Neutropenia, as side effect, 39, 42 Nevirapine, 98 Niacinamide, 44 Nicotinamide, 500 mg, with tetracycline, 44 Nifedipine 10 mg, 66 Nilstat, 22–23 Nizoral, 21 Nonherbal remedies, 90–93 Non-steroidal anti-inflammatory drugs (NSAIDs), 52, 55–56 Nortriptyline 10 or 25 mg, 82 Norvir, 98 Nov-Gel, 72–73 Nucynta, 62 Numoisen liquid and lozenge, 67–68 Nuprin, 58 Nutrient deficient and supplement therapy, 84–85 Nystatin contraindications for, 21, 31 ointment 100,000 IU, 23 100,000 units/g-triamcinolone acetonide 0.1% ointment, 23 100,000 units/g-triamcinolone acetonide 0.1% ointment with erythromycin gel 2%, 23–24 oral suspension (100,000 IU) 73 ml, with lidocaine, 40 oral suspension 100,000 IU/ ml, 22 pastilles or troches 200,000 IU, 22–23 topical powder 100, 000 IU, 23 with triamcinolone acetinomide suspension, 37 Occlusive dressings medications to avoid using with, 20 over-the-counter, 25–28 prescription, 24–25 Octagam, 40 122 www.ajlobby.com Peridex, Peridin-C, 51 Periodontal disease, 6, 61 Periodontitis, 6, 8, 10 PerioGard, Periostat, Peritonitis, with Candida, 18 Petoxifylline, 72 Pharyngitis, Phenergan, 12–13 Phenothiazines, 56, 59 Phenoxymethyl penicillin V 500 mg, Phentermine, 67 Phentolamine mesylate, 66 Phenylpropanolamine, 67 Phenytoin 100 mg, 82–83 Phos-Flur Rinse, 72 Photosensitivity, as side effect, Pilocarpine characterized,70, 72 HCl mg and 7.5 tablets, 70–71 4% ophthalmic solution, 71 Pimecrolimus, 1%, cream, 34 Podofin, 16–17 Podophyllum resin, 10%, and benzoin tincture compound solution, 16–17 Polocaine, 65 Polygam S/D, 40 Polyphenolsufonic acid complex, 100 ml, formaldehyde solution, 18 ml, distilled water, 42 ml, 16 Pontocain, 42 Povidone-iodine solution, 10% (Betadine), 10 Prednisolone syrup 15 mg/5 ml, 35–36 Prednisone cautionary notes, 28–29 10 mg, 34–35, 64 20 mg tablets, 35 20 mg tablets and 0.12% chlorhexidine gluconate mouthwash, 35 Prelone, 35–36 Oxycodone HCl 4.5 mg-oxycodone terephthalate 0.38 mgaspirin 325 mg, 59 mg-acetaminophen 325 mg, 59 mg and ibuprofen 400 mg, 61 Oxymorphone HCl 5, 10 mg, 20 mg, and 40 mg tablets, 61–62 Pain management See Analgesics Palifermin, 95 Pamelor, 82 Panglobulin NF, 40 Paraflex, 52 Parafon forte, 52 Paraproteinemia, 40 Patches oral canker sore, 26 OraMoist® mucoadhesive, 27, 70 OraPatch, 27–28 Pediatric medications See Children; Infants Pemphigoid bullous, 24, 30–31, 33, 36–37, 40–44 benign mucous membrane, 32, 34–36, 38–40, 44 Pemphigus, oral, 24, 30–33, 36–37, 40–44 Pen-Vee K liquid, 8–9 Penciclovir, 1%, cream, 49 Pencillin alternatives for, G 500 mg, influential medications, V potassium 250 or 500 mg, V potassium liquid 125 mg/5 ml, 8–9 Pentamidine, 86 Pentoxifylline 400 mg, 42 Percocet, 59 Percodan, 59 Perfect Choice, 73 123 www.ajlobby.com Qvar 40, 29 Prescription guidelines abbreviations, dangerous, 101–102 requirements, 100 safe writing practices, 100–101 topical corticosteroids, relative potencies of, 102–103 PreviDent characterized, 73, 76 5000 Booster, 73–74 5000 Dry Mouth (SLS free), 73–74 5000 Plus, 73–74 gel, 73 rinse, 73 Prezista, 97 Prilocaine 4%, with 1:200,000 epinephrine, 65 HCl, 4%, 65 Pro-Banthine, 72 Procardial, 66 Prochlorperazine contraindications to, 67 maleate mg, 55 Prograf, 43 Proleukin, 98 Promethazine HCl 25 mg, with meperidine HCl 50 mg, 63 syrup 6.25 mg/5 ml, 12 12.5 mg, 12 Propantheline bromide 7.5 mg or 15 mg, 72 Propoxycaine and procaine, 65–66 Prostheses, removable, overthe-counter disinfectants/ cleaners, 11–12 Protopic, 42–43 Prozac, 55, 82 Pseudoepinephrine, 67 Psychosis, 71 Ptyalism, 72 Pulmonary disease, 59, 66, 70 Purified salt of basic ferric sub sulfate, 78 Radiation patient management, 67, 93–97 Raltegravir, 98 Ravocaine, 65–66 Regranex, 45 Remune, 98 Renal diseases and disorders See Kidney diseases and disorders Reprexain-hydrocodone bitartrate 5.0 mg, 60–61 Rescriptor, 98 Reserpine, 67, 72 Respiratory depression, 63 Retin-A, 44–45 Retrovir, 97 Reyataz, 97 Reye’s syndrome, 57 Rheumatoid arthritis, 91 Rifampin, Rincinol P.R.N., 28 Ritabutin, Ritonavir, 98 Safe writing practices, prescription guidelines abbreviation intended meaning common error, 101–102 overview of, 100–101 Sal-Tropine, 72 Salistat-Tabs, 71 Saliva, generally aquoral artificial, 67 excessive, causes of, 72 inhibitors, for salivary hyperfunction, 72 Saliva stimulants, for chronic saliva hypofunction over-the-counter, 71 prescription, 70–71 Saliva Stimulant Tablets, 71 Saliva substitutes over-the-counter, short-term effect, 68 prescription, 67–68 Salix SST, 71 124 www.ajlobby.com allergic, 13 contact (delayed) allergic, 24, 30–33, 36–37, 40–44 herpetiform aphthous, 9, 35, 40 major aphthous, 32, 34–36, 38 recurrent aphthous, 24–27, 30–33, 36–37, 39–45, 70 as side effect, 76 Stop, 73 Streptococcus mutans, 68 pneumonia, pyogenes, 1–2 viridans, effective medications against, 8–9 Stroke, risk for, 57, 60–61 Sucralfate 6g, tetracaine 2%, distilled water 15 ml, 42 Sulphonylurea toxicity, 56 Sustiva, 98 Swabsticks, 25 Synalar, 32 Synalgos-DC, 60 Salogen, 70–71 Saquinavir mesylate, 98 Saw palmetto, 93 Scandonest 3% Plain, 65 Second-line therapies, 34 Seizure, as side effect, 62, 66 Seizure disorders, 93 Selective serotonin reuptake inhibitors, 62, 93 Selzentry, 98 Sepsis, 40 Septocaine, 64 Shingles See Varicella zoster Shock, as side effect, 63 Silver nitrate, 16 Sinequan, 55, 81–82 Sinusitis, maxillary, Sjögren’s syndrome, 67 Sodium fluoride 0.05%, 75 5%, varnish, 76 Spectracef, Splints, 29 Sporanox, 20–21 Sporothrix, 20 Sprix, 61 Spry Dry Mouth Gum, 69 Regular/Fluoride toothpaste, 69 St John’s wort, 93 Stan-Gard, 72–73 Stannous fluoride gel, 0.4%, 72–73, 97 Staphylocci effective medications against, 5, Staphylococcus aureus, 1, 10 Stavudine, 97 Steroids alternatives to, 38–45 cautionary notes, 28–29 compounded solutions, 29 over-the-counter alternatives to, 45 overview of, 29–38 topical wound repair, 45 Stomatitides, oral erosive, 31 Stomatitis Tabasco® sauce, 84 Tacrolimus 0.03%, ointment, 42–43 1.0 mg capsule mixed with purified water and oral rinse, 43 Tagamet HB 200, 45 Tapentadol HCl 50 mg, 62 Taste and smell disorder therapies drugs that affect taste and smell, 86 over-the-counter medications, 85 prescription medications, 85 referral centers, 85–86 vitamins and supplements, 85 zinc deficiency and, 85 Tegretol, 64, 79 Temovate, 21, 31 Tenofovir characterized, 99 disoproxil fumarate, 97 Terfenadine, contraindications, 125 www.ajlobby.com Toothpastes Colgate Total, 10 over-the-counter, 69 over-the-counter sodium-lauryl sulfate-free, 90 Toradol, 59 Tramadol, 62 Tramadol HCl 50 mg, 62 Tranexamic acid, 77–78 Traxene, 53 Trazodone characterized, 67 HCl 50 mg, 55, 83 Trental, 42 Tretinoin, 0.1%, ointment, 44–45 Triamcinolone acetinomide injectable 25- and 40-mg/ml suspension, 38 0.1% aqueous suspension, 36–37 0.1% cream, 103 0.1% ointment, 23–24, 102 0.1% ointment in Orabase or Orabase with benzocaine, 36 0.1% or 0.5%, ointment, 36 0.1% suspension in 2% viscous lidocaine, 37 0.1% suspension with nystatin suspension, 37 0.025% cream, 103 Trifluoperzine, 67 Trimethoprim 80 mg and sulfamethoxazole 400 mg, 10 Trimox, Trizivir, 97 True Gel, 72–73 Tylenol, regular strength, 57 See also Acetaminophen Tetracaine, 2%, gel, 51 Tetracycline characterized, 45 oral suspension (125 mg/5 ml) 18 ml, with lidocaine, 40 side effects of, 86 Tetracycline HCl characterized, 500 mg, 500 mg and nicotinamide 500 mg, 44 oral suspension (125 mg/5ml), 43 oral suspension (125 mg/5 ml) 18 ml, dexamethasone elixir (0.5 mg/5 ml) ml, diphenhydramine elixir (12.5 mg/5 ml) 173 ml, 44 oral suspension 250 mg/tsp, 2.7 mg, 10 250 mg, 9–10 Tetracyn, 9–10 Theophylline contraindications for, 66 drug interactions with, 6, 49 toxicity, 4, Thera-Flur, 73 Thera-Flur-N, 73 TheraDent oral rinse, 76 Thiazides, 67 Thioridazine, 67 Thiothixene, 67 Thiouracil, contraindications for, 66 Thrombin, 77 Thromboembolic disease, 78 Thrombogen, 77 Tipranavir, 98 TMD, 62 TMJ pain, 52 Tom’s of Maine® toothpaste, 69 Tonsilitis, Tooth/teeth desensitizers, 75–76 hypersensitive, 75–76 staining, as side effect, 3–4, 9–10, 96 Ulcer(s) aphthous, 25, 28, 38, 96 major aphthous, 29 minor aphthous, 16 neuropathic, 45 oral, 28 peptic, 57 126 www.ajlobby.com Ulceration, soft tissue, 43 Ulcerative colitis, as side effect, Ulcerative diseases, 24–28, 45 Ulcerease, 96 Ultram/Ultram ER, 62 Ultravate, 33 Urecholine, 70 Urolithiasis, 71 Warfarin, Weisman’s Philadelphia mouthwash, 13 Women’s health guidelines hormone suppression, 90 lactation, 90 menopause, 90 pregnancy, 5–6, 38, 42, 53, 57, 90, 92–93 vaginal creams, 24 women of child-bearing age, 41, 93 Wound repair, topical, 45 Wymox, Vaginal creams, 24 Valacyclovir HCl 500 mg, 49–50 Valcyte, 97 Valganciclovir, 97 Valisone, 30 Valium, 54, 81 Valproic acid, 72 Valtrex, 49–50 Vancocin, 10 Vancomycin 125 mg, 10 Varicella characterized, generally, 46 zoster, 34, 47–49 Vasoactive drugs, 66 Vesicular disease, chronic oral, 45 Vestibular diseases, 24–28 Vibramycin, 5–6, Vicodin, 60 Vicoprofen, 60–61 Videx, 97 Viracept, 98 Viractin, 51 Viral-blocking agents, 46–51 Viramune, 98 Viread, 97 Viroxyn, 50–51 Vistaril, 54 Vitamin deficiency, 84 VitiGam, 39 Vivacaine, 64 Volume depletion, 40 Xanax characterized, 53, 78 XR, 53, 78–79 Xerclear, 48 Xerese, 48 Xerostomia, drugs reported to cause, 12, 67–75, 82 Xerostomic patients, 63 Xylitol, 69 Xylocaine, 14–15, 64 Zalcitabine, 97 Z-Bec, 85 Zerit, 97 Ziagen, 97 Zidovudine with abacavir and lamivudine, 97 influential medications, 4, 97 Zilactin-L gel, 28 Zinc deficiency, 85 Zithromax, Zmax, Zorcaine, 64 Zostrix, 79, 83–84 Zovirax, 46–48 127 www.ajlobby.com www.ajlobby.com .. .Your Pocket- Size Dental Drug Reference 2012 Edition A Handbook of Commonly Used Dental Medications Useful in the Management of Oral Diseases... Library of Congress Cataloging-in-Publication Data Kahn, Michael A Your pocket- size dental drug reference : a handbook of commonly used dental medications useful in the management of oral diseases... diseased pocket (variable dose depending on size, shape, and number of pockets being treated) www.ajlobby.com Use: An adjunct to scaling and root planing procedures for the reduction of pocket